|Summary||A nootropic drug of the racetam class, originally developed to treat Alzheimer's disease, it is currently being investigated as a treatment for major depressive disorder and generalised anxiety disorder. May be a modulator of the AMPA receptor. Limited recreational value.|
|Dose||Oral Light: 3-5mg Common: 5-10mg Strong: 10-20mg+ |
Sublingual/Insufflated Light: 2-5mg Common: 5-10mg Strong: 10mg+
|Onset||Oral: 15-30 minutes. |
Sublingual: 5-10 minutes.
Intranasal: 1-5 minutes
|Duration||3-6 hours depending on stomach contents/ROA/ect.|